Literature DB >> 861127

Determinants of response to frusemide in normal subjects.

R A Branch, C J Roberts, M Homeida, D Levine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 861127      PMCID： PMC1429020          DOI： 10.1111/j.1365-2125.1977.tb00682.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  13 in total

1.  RELATIONSHIP BETWEEN HG-203 EXCRETION RATE AND DIURETIC RESPONSE FOLLOWING HG-203 MERCAPTOMERIN SODIUM ADMINISTRATION.

Authors:  G LEVY; B CALESNICK; A WASE
Journal:  J Nucl Med       Date:  1964-04       Impact factor: 10.057

2.  On the fate of furosemide in man.

Authors:  B Beermann; E Dalén; B Lindström; A Rosén
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

Review 3.  Bioavailability of drugs (second of two parts).

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1974-09-05       Impact factor: 91.245

4.  Pharmacokinetics and pharmacodynamics of Lasix.

Authors:  W Rupp
Journal:  Scott Med J       Date:  1974       Impact factor: 0.729

5.  Aldosterone and its regulation during diuresis in patients with gross congestive heart failure.

Authors:  M G Nicholls; E A Espiner; R A Donald; H Hughes
Journal:  Clin Sci Mol Med       Date:  1974-10

6.  Determination of furosemide in blood plasma and its binding to proteins in normal plasma and in plasma from patients with acute renal failure.

Authors:  F Andreasen; P Jakobsen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-07

7.  Pharmacokinetics of orally administered furosemide.

Authors:  M R Kelly; R E Cutler; A W Forrey; B M Kimpel
Journal:  Clin Pharmacol Ther       Date:  1974-02       Impact factor: 6.875

8.  Pharmacokinetics of furosemide in normal subjects and functionally anephric patients.

Authors:  R E Cutler; A W Forrey; T G Christopher; B M Kimpel
Journal:  Clin Pharmacol Ther       Date:  1974-06       Impact factor: 6.875

9.  [Examples of phase I: diuretics].

Authors:  W Rupp; R M Zapf
Journal:  Arzneimittelforschung       Date:  1973-11

10.  Furosemide. A clinical evaluation of its diuretic action.

Authors:  W B Stason; P J Cannon; H O Heinemann; J H Laragh
Journal:  Circulation       Date:  1966-11       Impact factor: 29.690
View more
  35 in total

Review 1.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

2.  Diuretic effect and disposition of furosemide in cystic fibrosis.

Authors:  J Prandota; I J Smith; B C Hilman; J T Wilson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of frusemide.

Authors:  R E Cutler; A D Blair
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

Review 4.  Resistance to loop diuretics. Why it happens and what to do about it.

Authors:  D C Brater
Journal:  Drugs       Date:  1985-11       Impact factor: 9.546

5.  Pharmacokinetics of furosemide in gestosis of pregnancy.

Authors:  E Riva; P Farina; G Tognoni; S Bottino; C Orrico; G Pardi
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

6.  Pharmacokinetics/pharmacodynamics of furosemide in man: a review.

Authors:  L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

7.  Furosemide disposition in patients on CAPD.

Authors:  U Martin; R J Winney; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

8.  Evaluation of potential causes for the incomplete bioavailability of furosemide: gastric first-pass metabolism.

Authors:  M G Lee; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1983-12

Review 9.  Influence of drug formulation on drug concentration-effect relationships.

Authors:  G Castañeda-Hernández; G Caillé; P du Souich
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

10.  Determinants of the diuretic response to furosemide in infants with congestive heart failure.

Authors:  T P Green; B L Mirkin
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.